Claficapavir
Product Specifications
UNSPSC Description
Claficapavir (A1752) is a specific nucleocapsid protein (NC) inhibitor with an IC50 around 1 μM. Claficapavir strongly binds the HIV-1 NC (Kd=20 nM) thereby inhibiting the chaperone properties of NC and leading to good antiviral activity against the HIV-1[1].
Target Antigen
HIV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/claficapavir.html
Solubility
DMSO : 200 mg/mL (ultrasonic;warming;heat to 40°C)
Smiles
O=C(N(C(S/1)=S)CCC(O)=O)C1=C\C2=CC=C(C3=CC=C(C=C3)Cl)O2
Molecular Weight
393.86
References & Citations
[1]Kim MJ, et al. Identification and characterization of a new type of inhibitor against the human immunodeficiency virus type-1 nucleocapsid protein. Retrovirology. 2015;12:90. Published 2015 Nov 6.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-145560/Claficapavir-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-145560/Claficapavir-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2055732-24-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS2085156-01 0.1 mL
PE-Linked Polyclonal Antibody to Angiopoietin Like Protein 7 (ANGPTL7)
Ask
View Details